Bone Marrow TransplantationTransplantation, HomologousGraft vs Host DiseaseBone MarrowWhole-Body IrradiationBone Marrow CellsLeukemiaTransplantation ConditioningAnemia, AplasticTransplantation ChimeraTransplantation, AutologousBusulfanTissue DonorsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHematopoietic Stem Cell TransplantationGraft SurvivalGraft vs Tumor EffectHistocompatibility TestingLeukocyte TransfusionRecurrenceHistocompatibilityRadiation ChimeraTransplantation, IsogeneicHematologic NeoplasmsGraft vs Host ReactionLeukemia, Myeloid, AcuteT-LymphocytesPrecursor Cell Lymphoblastic Leukemia-LymphomaGraft vs Leukemia EffectLymphocyte DepletionRemission InductionCyclophosphamideLymphocyte TransfusionMice, Inbred C57BLImmunosuppressionAcute DiseaseHepatic Veno-Occlusive DiseaseBone and BonesTransplantation ImmunologyImmunosuppressive AgentsLeukemia, MyeloidBone Marrow PurgingCombined Modality TherapyGraft RejectionChimeraHematopoietic Stem CellsIsoantigensTime FactorsLymphocyte Culture Test, MixedMyelodysplastic SyndromesTreatment OutcomeNuclear FamilyHLA AntigensHematopoiesisCyclosporineMice, Inbred BALB CLiver TransplantationSurvival AnalysisSpleenActuarial AnalysisCytomegalovirus InfectionsRetrospective StudiesLymphocyte ActivationHematologic DiseasesFatal OutcomeLymphoma, Non-HodgkinSevere Combined ImmunodeficiencySkin TransplantationCytotoxicity, ImmunologicLymphocytesCytarabineSurvival RateBone Marrow DiseasesAntineoplastic Combined Chemotherapy ProtocolsKidney TransplantationFollow-Up StudiesStem Cell TransplantationMice, Inbred C3HImmune ToleranceGranulocyte Colony-Stimulating FactorPancytopeniaDisease-Free SurvivalLeukocyte CountFlow CytometryMice, Inbred StrainsAnemia, Refractory, with Excess of BlastsLeukemia, Myelomonocytic, AcuteThymus GlandInfectionLymphomaMethotrexateNeoplasm, ResidualBone Marrow ExaminationEtoposideCells, CulturedAntilymphocyte SerumMultiple MyelomaGanciclovirAntibodies, MonoclonalCyclosporins